COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
Natália Souza Freitas QueirozCamilla de Almeida MartinsAbel Botelho QuaresmaAdriano A F HinoFlavio SteinwurzRyan C UngaroPaulo G KotzePublished in: Journal of gastroenterology and hepatology (2021)
Inflammatory bowel disease patients with COVID-19 in Latin America appear to have similar outcomes to the overall global data. Risk factors of severe COVID-19 are similar to prior reports.